LIGAND PHARMACEUTICALS INCORPORATED Sale Leaseback Transaction, Current Period Gain Recognized
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Sale Leaseback Transaction, Current Period Gain Recognized of -$3.69 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-23.
Discontinued › Income Statement › Other Income
us-gaap:SaleLeasebackTransactionCurrentPeriodGainRecognized · last filed 2015-02-23
- LIGAND PHARMACEUTICALS INCORPORATED sale leaseback transaction, current period gain recognized for the quarter ending 2011-12-31 was $425.00K, a 0.00% change year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED sale leaseback transaction, current period gain recognized for the quarter ending 2011-09-30 was $426.00K, a 0.00% change year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED sale leaseback transaction, current period gain recognized for the quarter ending 2011-06-30 was $426.00K, a 0.00% change year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED sale leaseback transaction, current period gain recognized for the quarter ending 2011-03-31 was $426.00K.
- LIGAND PHARMACEUTICALS INCORPORATED sale leaseback transaction, current period gain recognized for fiscal 2014 was -$3.69M.
- LIGAND PHARMACEUTICALS INCORPORATED sale leaseback transaction, current period gain recognized for fiscal 2013 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED sale leaseback transaction, current period gain recognized for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- LIGAND PHARMACEUTICALS INCORPORATED sale leaseback transaction, current period gain recognized for fiscal 2011 was $1.70M, a 0.00% change from fiscal 2010.
| Period end | Sale Leaseback Transaction, Current Period Gain Recognized 3 month | Sale Leaseback Transaction, Current Period Gain Recognized 6 month | Sale Leaseback Transaction, Current Period Gain Recognized 9 month | Sale Leaseback Transaction, Current Period Gain Recognized 12 month | Sale Leaseback Transaction, Current Period Gain Recognized 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | -$3.69M 10-K · filed 2015-02-23 | $0.00 10-K · filed 2014-12-01 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-02-23 | ||||
| 2012-12-31 | $0.00 10-K · filed 2015-02-23 | ||||
| 2011-12-31 | $425.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | $851.00K derived: sum of 2 quarters · filed 2014-12-12 | $1.28M derived: sum of 3 quarters · filed 2014-12-12 | $1.70M 10-K/A · filed 2014-12-12 | |
| 2011-09-30 | $426.00K 10-Q · filed 2012-11-14 | $852.00K derived: sum of 2 quarters · filed 2012-11-14 | $1.28M 10-Q · filed 2012-11-14 | $1.70M derived: sum of 4 quarters · filed 2013-03-14 | |
| 2011-06-30 | $426.00K 10-Q/A · filed 2012-11-14 | $851.00K 10-Q/A · filed 2012-11-14 | $1.28M derived: sum of 3 quarters · filed 2013-03-14 | $1.70M derived: sum of 4 quarters · filed 2013-03-14 | |
| 2011-03-31 | $426.00K 10-Q/A · filed 2012-11-14 | $851.00K derived: sum of 2 quarters · filed 2013-03-14 | $1.28M derived: sum of 3 quarters · filed 2013-03-14 | $1.70M derived: sum of 4 quarters · filed 2013-03-14 | |
| 2010-12-31 | $425.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-14 | $851.00K derived: sum of 2 quarters · filed 2013-03-14 | $1.28M derived: sum of 3 quarters · filed 2013-03-14 | $1.70M 10-K · filed 2013-03-14 | |
| 2010-09-30 | $426.00K 10-Q/A · filed 2012-02-10 | $852.00K derived: sum of 2 quarters · filed 2012-02-10 | $1.28M 10-Q/A · filed 2012-02-10 | ||
| 2010-06-30 | $426.00K 10-Q/A · filed 2012-02-10 | $851.00K 10-Q/A · filed 2012-02-10 | |||
| 2009-12-31 | $21.85M 10-K/A · filed 2012-11-14 |